Cell-replacement Therapy for Parkinson's Disease Holds Promise for Sufferers

Cell-replacement therapy involves differentiating stem cells into dopamine-signaling, neurons and transplanting them into Parkinson's patient’s brain. This therapy shows some promise as a treatment for Parkinson's

Cell-replacement therapy shows some promise as a treatment for Parkinson's disease. This therapy involves differentiating stem cells into dopamine-signaling neurons and transplanting them to replace dying neurons. A recent paper in the journal Molecular & Cellular Proteomics reports a technical advance in selecting cells to use in this therapy.//

Parkinson's disease is a neurodegenerative disorder that affects dopamine signaling neurons in patients' brains.The variability of differentiated cells -- including contamination with other neuronal cell types or residual undifferentiated stem cells -- can affect transplantation outcomes.

Researchers Identify First Step in Strategy for Cell Replacement Therapy in Parkinson's Disease
Induced pluripotent stem cells (iPSC) are a promising avenue for cell replacement therapy in neurologic diseases.

‘Cell-replacement therapy involves differentiating stem cells into dopamine-signaling neurons and transplanting them to replace dying neurons.’

In clinical trials in the 1990s, for example, such contamination gave some patients severe dyskinesia, uncontrollable jerky movements that were worse than the movement problems caused by Parkinson's disease.

To avoid interference by unwanted cell types, researchers need a differentiation protocol that yields a more homogeneous population of dopaminergic neurons.

Researchers led by Hossein Baharvand, of Iran's University of Science and Culture in Tehran, and Ghasem Hosseini Salekdeh , of the Academic Center for Education, Culture and Research in Iran and Macquarie University in Australia, set out to develop such a protocol.

Study Leads to New Treatment for Parkinson's
Study provides important clues about new molecular means for reducing cytoplasmic aggregates in Parkinson's disease.

First, the team developed a special stem cell line that contains a green fluorescent protein, or GFP, reporter for a transcription factor involved in dopaminergic neuronal development.

In undifferentiated cells from this line, the fluorescent reporter is not expressed. When cells begin to make the transcription factor, the first step toward becoming a dopaminergic neuron, they also begin to make the GFP protein.

Advantages of Virtual Games to Improve Quality of Life in Parkinson�s Disease
The main objective in rehabilitation by virtual reality is to increase functional ability and raise participation of the Parkinson’s disease patient in daily life.

The team then used standard protocols to differentiate the cells and sorted them by GFP expression. They then identified proteins that were enriched on the surface of partially differentiated cells called dopaminergic progenitors.

By selecting for one protein characteristic of dopaminergic progenitors, called contactin 2, they isolated progenitors and transplanted them into rats modeling Parkinson's disease.

Nutritional Management of Parkinson's Disease
Parkinson's disease is a brain disorder which leads to many other related effects. Nutrition plays an important role in management of the disease.

Rats that received transplants with contactin 2-enriched cells had better dopamine release, indicating that the transplanted cells were a better match for the dying neurons they were meant to replace.

Sorting the cells also reduced motor symptoms of Parkinson's compared with rats treated that received unsorted cells.

The team's isolation procedure uses may be an important step toward more successful cell-replacement therapy.

Source-Eurekalert